Anika Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ANIK Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
14 Mar 24	BuyUS$304,411	Caligan Partners, LP	Company	12,500	US$24.35
06 Mar 24	BuyUS$12,203,182	Caligan Partners, LP	Company	472,133	US$27.13
05 Mar 24	SellUS$70,351	William Jellison	Individual	2,700	US$26.06
27 Feb 24	SellUS$3,507,652	Caligan Partners, LP	Company	140,200	US$25.26

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ANIK?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	447,850	3.06%
General Public	824,115	5.63%
Hedge Funds	3,559,590	24.3%
Institutions	9,814,041	67%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 79.28% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.5%	Trigran Investments, Inc.	2,124,460	US$34.6m	-0.55%	4.11%
12.1%	BlackRock, Inc.	1,764,607	US$28.8m	9.81%	no data
9.8%	Caligan Partners, LP	1,435,130	US$23.4m	-0.06%	7.53%
5.45%	The Vanguard Group, Inc.	798,643	US$13.0m	1.08%	no data
4.83%	Dimensional Fund Advisors LP	707,366	US$11.5m	-5.59%	no data
3.92%	Renaissance Technologies LLC	574,229	US$9.4m	-4.01%	0.01%
3.44%	Boothbay Fund Management, LLC	503,838	US$8.2m	0.38%	0.28%
3.06%	Acadian Asset Management LLC	448,784	US$7.3m	1.32%	0.02%
2.22%	Geode Capital Management, LLC	324,964	US$5.3m	-4.72%	no data
2.08%	State Street Global Advisors, Inc.	305,225	US$5.0m	-2.45%	no data
2.07%	Morgan Stanley, Investment Banking and Brokerage Investments	303,417	US$4.9m	-14%	no data
2.02%	Alta Fundamental Advisers LLC	296,082	US$4.8m	0%	2.09%
1.98%	The Capital Management Corporation	290,350	US$4.7m	-11.7%	0.85%
1.62%	Meros Investment Management, LP	237,295	US$3.9m	11.6%	1.68%
1.29%	Stonepine Capital Management LLC	189,308	US$3.1m	14.5%	1.12%
1.2%	Cheryl Blanchard	175,160	US$2.9m	0%	no data
1.05%	D. E. Shaw & Co., L.P.	154,061	US$2.5m	0.74%	no data
1.02%	Charles Schwab Investment Management, Inc.	149,956	US$2.4m	-0.13%	no data
1.02%	Eaton Vance Management	149,560	US$2.4m	0.36%	no data
0.91%	Franklin Resources, Inc.	133,274	US$2.2m	-5.89%	no data
0.84%	Northern Trust Global Investments	123,310	US$2.0m	-5.1%	no data
0.74%	Segall Bryant & Hamill, LLC	108,799	US$1.8m	1.68%	0.02%
0.74%	Arrowstreet Capital, Limited Partnership	108,793	US$1.8m	0%	no data
0.7%	Epoch Investment Partners, Inc.	102,783	US$1.7m	108%	0.03%
0.7%	Riverwater Partners LLC	101,996	US$1.7m	539%	0.85%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 22:10
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Anika Therapeutics, Inc. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Michael Petusky	Barrington Research Associates, Inc.
Mark Landy	Northland Capital Markets
James Sidoti	Sidoti & Company, LLC